Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Innovent Announces the New Drug Application of IBI311 (IGF-1R antibody) has been Accepted by the NMPA of China for Thyroid Eye Disease 2024-05-21 08:55
Telix Completes Proof-of-Concept Study of TLX592 Targeted Alpha Therapy in Prostate Cancer 2024-05-21 07:58
HaemaLogiX welcomes former Australian Federal Minister for Health Professor the Hon Greg Hunt to the company board as Non-Executive Director 2024-05-20 18:00
GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Approval 2024-05-20 14:07
Innovent Announces Oral Presentations at ESMO Plenary and ESMO GI Congress on Clinical Data of IBI363 (PD-1/IL-2) and IBI343 (CLDN18.2 ADC) 2024-05-20 08:20
Qilian International plans to adjust industrial investment 2024-05-17 22:00
LiveSpo Pharma Emerges as Vietnam's Pioneer at Vitafoods Europe 2024, Unveiling Groundbreaking Research and Product Development to Reduce Antibiotic Use in Digestive and Respiratory Care 2024-05-17 18:33
Full-Life Technologies Announces Appointment of Mark S. de Jong, PhD, as Chief Technical Officer 2024-05-17 08:00
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality 2024-05-17 07:00
Seegene and Springer Nature Announce Strategic Alliance 2024-05-16 21:00
Fosun International Earns a Spot on "2024 Fortune China ESG Impact List" 2024-05-16 11:15
EHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for Presentations at 2024 European Hematology Association Hybrid Congress 2024-05-16 09:03
Ractigen Therapeutics Receives IND Approval from China's NMPA to Initiate Phase 1 Clinical Trials for RAG-17 in SOD1-ALS Patients 2024-05-15 20:00
Everest Medicines Announces Commercial Launch and First Prescription for NEFECON® in Mainland China 2024-05-14 21:41
Novosis Putty Sets the Stage for U.S. Market Success with Promising Clinical Results 2024-05-14 20:00
Mabwell Announces Clinical Trial Progress of 9MW2821 in Triple-Negative Breast Cancer 2024-05-13 22:00
SCG Cell Therapy Presented New Preclinical Data in an Oral Presentation at ASGCT 2024 Annual Meeting Highlighting Superior Tumor Inhibition of its Immunoswitch Armored HPV-TCR T Cell Therapy (SCG142) against a Broad Range of HPV-associated Cancers 2024-05-13 10:00
Caliway to Present the Latest Clinical Advancements at 2024 BIO International Convention 2024-05-11 15:14
Single-Cell Multi-Omics Analysis of IASO Bio's Equecabtagene Autoleucel in the Treatment of Autoimmune Diseases of the Central Nervous System Published in Science Immunology 2024-05-11 10:16
China Jo-Jo Drugstores Announces $2.74 Million Registered Direct Offering 2024-05-10 21:20
1 34 35 36 37 38 412